- Home
- AUTL vs BWFG Comparison
AUTL vs BWFG Comparison
Compare AUTL & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | BWFG |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 525.2M |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AUTL | BWFG |
|---|---|---|
| Price | $1.60 | $65.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | $8.73 | ★ $69.50 |
| AVG Volume (30 Days) | ★ 1.5M | 53.6K |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | N/A | ★ 261.79 |
| EPS | N/A | ★ 2.95 |
| Revenue | ★ $10,120,000.00 | $2,826,000.00 |
| Revenue This Year | $98.68 | $19.65 |
| Revenue Next Year | $28.47 | $6.50 |
| P/E Ratio | ★ N/A | $22.09 |
| Revenue Growth | ★ 496.00 | 43.96 |
| 52 Week Low | $1.18 | $40.99 |
| 52 Week High | $2.58 | $69.59 |
Technical Indicators
Market Signals| Indicator | AUTL | BWFG |
|---|---|---|
| Relative Strength Index (RSI) | 35.87 | 47.15 |
| Support Level | $1.37 | $63.57 |
| Resistance Level | $1.73 | $69.22 |
| Average True Range (ATR) | 0.09 | 1.25 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 6.41 | 50.37 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.